Home Recalls D-0621-2024
Class II · Moderate risk Ongoing Initiated Jul 22, 2024 (2 years ago)
Glenmark, Azelaic Acid Gel, 15 %, 50 grams, Rx only, Manufactured by: Glenmark…
Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.
Why it was recalled
CGMP Deviations
What was recalled
Glenmark, Azelaic Acid Gel, 15 %, 50 grams, Rx only, Manufactured by: Glenmark Pharmaceuticals Limited, Colvale-Bardez, Goa, 403513, India, Manufactured for: Glenmark Pharmaceuticals Inc., USA, Mahwah, NJ 07430, NDC 68462-626-52.
Recalling firm Glenmark Pharmaceuticals Inc., USA
NDC code 68462-626-52
Origin NJ, United States
Initiated by Voluntary: Firm initiated
FDA recall number D-0621-2024
What should you do? A recall doesn't always mean your specific bottle is affected - it often applies to certain lots only. Check the lot number on your package against the FDA notice, and talk to your pharmacist before stopping any medication.
Class II · Moderate risk Ongoing Jul 23, 2026
Reason CGMP Deviations: Product quality complaints concerning abnormal texture or consistency (described as grainy, gritty, or sandy) were received.
Class II · Moderate risk Ongoing Sep 17, 2025
Reason CGMP Deviations: Market complaints received for gritty texture (grainy)
Class II · Moderate risk Terminated Jul 15, 2021
Reason cGMP Deviations
Class II · Moderate risk Terminated Feb 10, 2017
Reason Lack of Assurance of Sterility: There are also CGMP Deviations.
Class II · Moderate risk Terminated Feb 10, 2017
Reason Lack of Assurance of Sterility: There are also CGMP Deviations.